Evidence Passport
A Generative AI-powered navigation system for precision CBCT-guided lung biopsies: a randomised controlled trial
Top story 3 in the issue of 22 October 2026, in 04 AI Healthcare.
Original source
GPS-Lung cut needle punctures (2.0 vs 2.5), procedure time (20.4 vs 23.2 min), radiation dose and pneumothorax (12.7% vs 23.9%) against standard guidance.
Evidence
Evidence: Peer-reviewed (evidence step 5 of 6)
Published after review by independent experts.
Bottleneck: Safe, accurate needle placement in lung biopsy Progress
The story in three lines
- Key finding
- In a multicentre RCT, AI navigation lowered pneumothorax after lung biopsy from 23.9% to 12.7% and cut punctures, time and radiation.
- Significance
- Clinical: a randomised trial, not a retrospective test, showing fewer complications in an everyday procedure.
- Takeaway
- Strong evidence for this setting; wider replication and longer follow-up should come before routine use.
Study details (as stated by the source)
- Study design
- Multicentre randomised controlled trial (NCT06762613)
- Outcomes
- Punctures, procedure time, radiation dose, pneumothorax
Later coverage in the journal
No later coverage in the journal yet.
Corrections and updates
No corrections or updates recorded for this item.
This page is generated from the issue and stays at the same address. It adds nothing that is not in the issue, the source link or the corrections log.